Robert Califf is commissioner of the Food and Drug Administration. From 2015 until February 2016, he was FDA deputy commissioner for medical products and tobacco. Califf was previously a medicine professor and vice chancellor for clinical and translational research at Duke University, where he directed the Duke Translational Medicine Institute and was founding director of the Duke Clinical Research Institute. An expert in cardiovascular medicine, health outcomes research, and health care quality, Califf has more than 1,200 publications in peer-reviewed literature. His board service includes multiple Institute of Medicine committees, the FDA Cardiorenal Advisory Panel, and the Board of Scientific Counselors for the NIH and National Library of Medicine.
